DBV Technologies reported 16.34M in Trade Creditors for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Creditors Change
DBV Technologies DBVT:US 16.34M 4.92M
Acadia Pharmaceuticals ACAD:US $ 11.85M 1.09M
Alnylam Pharmaceuticals ALNY:US $ 52.42M 2.5M
Amarin AMRN:US $ 116.31M 25.56M
Eleven Biotherapeutics EBIO:US 666K 2.19M
Esperion Therapeutics ESPR:US $ 12.83M 14M
Galectin Therapeutics GALT:US $ 2.96M 1.06M
Halozyme Therapeutics HALO:US $ 12.23M 10.97M
Insmed INSM:US $ 31.14M 17.43M
Intercept Pharmaceuticals ICPT:US $ 11.67M 1.28M
IONIS PHARMACEUT IONS:US $ 10.35M 5.77M
Ptc Therapeutics PTCT:US $ 22.88M 4.52M
Sarepta Therapeutics SRPT:US $ 56.21M 2.2M
Ultragenyx Pharmaceutical RARE:US $ 34.21M 10.53M
YTE INCY:US $ 194.77M 42.22M